McKinsey Agrees to $650 Million Criminal Settlement for Role in 'Turbocharging' Opioid Sales for Purdue Pharma
McKinsey & Company agrees to pay $650 million to settle federal criminal and civil investigations into its role in helping Purdue Pharma ’turbocharge’ sales of OxyContin, the highly addictive opioid painkiller at the center of America’s overdose epidemic. This marks the first …
McKinsey & Company
U.S. Department of Justice
Purdue Pharma
Martin Elling
Food and Drug Administration (FDA)
mckinsey
opioid-crisis
purdue-pharma
consulting-scandal
corporate-crime
+4 more
Read more →